News | News By Subject | News by Disease News By Date | Search News

Immune/Idiopathic Thrombocytopenic Purpura (ITP) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News

News from Around the Web
No News Posted on that date

Press Releases
Protalex, Inc. (PRTX) Announces Presentation Of Preclinical Data With PRTX-100 Supporting Treatment Of Immune Thrombocytopenia At The American Society of Hematology 57th Annual Meeting And Exposition     11/11/2015
Symphogen A/S and Swedish Orphan Biovitrum Receive U.S. Orphan Drug Designation for Rozrolimupab in ITP     10/6/2010
Immunomedics, Inc. (IMMU) Reports Updated Results of Low-Dose Veltuzumab for Immune Thrombocytopenic Purpura     6/5/2009
CSL Behring Release: Study Shows Privigen(TM) 10% Liquid Immunoglobulin Preparation for Intravenous Use, Is an Effective Replacement Therapy in Patients with Primary Immune Deficiencies     3/17/2008
Endocyte Receives Notice Of A U.S. Patent Allowance For A Targeted Immunotherapy Treatment     11/2/2005
Labeling For Gamunex Now Includes Assurances Of Removal Of Pathogenic Prions During Manufacture; First Liquid IGIV Therapy To Carry FDA-Approved Labeling For TSE Removal Demonstrates Continued Talecris Biotherapeutics Leadership In Pathogen Safety     7/7/2005
CytoGenix, Inc. (CYGX) Invents Revolutionary Large-Scale Manufacturing Process For High-Purity DNA     12/14/2004